[HTML][HTML] Neutralizing antibodies for the prevention and treatment of COVID-19

L Du, Y Yang, X Zhang - Cellular & molecular immunology, 2021 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …

[HTML][HTML] Follow-ups on persistent symptoms and pulmonary function among post-acute COVID-19 patients: a systematic review and meta-analysis

Q Long, J Li, X Hu, Y Bai, Y Zheng, Z Gao - Frontiers in medicine, 2021 - frontiersin.org
Objective: As the number of recovering COVID-19 patients increases worldwide, the
persistence of symptoms and signs through the post-acute phase indicates an urgent need …

[HTML][HTML] SARS-CoV-2 B. 1.1. 7 (alpha) and B. 1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains

P Radvak, HJ Kwon, M Kosikova… - Nature …, 2021 - nature.com
SARS-CoV-2 variants of concern (VOC) B. 1.1. 7 (alpha) and B. 1.351 (beta) show increased
transmissibility and enhanced antibody neutralization resistance. Here we demonstrate in …

[HTML][HTML] Dysautonomia in COVID-19 patients: a narrative review on clinical course, diagnostic and therapeutic strategies

F Carmona-Torre, A Mínguez-Olaondo… - Frontiers in …, 2022 - frontiersin.org
Introduction On March 11, 2020, the World Health Organization sounded the COVID-19
pandemic alarm. While efforts in the first few months focused on reducing the mortality of …

[HTML][HTML] A systematic review of vaccine breakthrough infections by SARS-CoV-2 delta variant

M Zhang, Y Liang, D Yu, B Du, W Cheng… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
Vaccines are proving to be highly effective in controlling hospitalization and deaths
associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway

Y Wang, X Wang, Y Li, Z Xue, R Shao, L Li, Y Zhu… - Pharmacological …, 2022 - Elsevier
The pathogenic hyper-inflammatory response has been revealed as the major cause of the
severity and death of the Corona Virus Disease 2019 (COVID-19). Xuanfei Baidu Decoction …

Rapid field determination of SARS-CoV-2 by a colorimetric and fluorescent dual-functional lateral flow immunoassay biosensor

H Han, C Wang, X Yang, S Zheng, X Cheng… - Sensors and Actuators B …, 2022 - Elsevier
The rapid and accurate diagnosis of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) at the early stage of virus infection can effectively prevent the spread of the …

[HTML][HTML] The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses

A Schreiber, D Viemann, J Schöning, S Schloer… - Cellular and Molecular …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), the illness caused by a novel coronavirus
now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to more …

[HTML][HTML] The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment

M Wang, Y Zhang, C Li, W Chang, L Zhang - Frontiers in Immunology, 2023 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has posed a global health crisis. Increasing …

Digital PCR applications in the SARS-CoV-2/COVID-19 era: a roadmap for future outbreaks

R Nyaruaba, C Mwaliko, D Dobnik… - Clinical Microbiology …, 2022 - Am Soc Microbiol
The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global public health …